Clinical Trial Update: DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin) [Phase 4]

View source ↗

Summary

This document summarizes a completed Phase 4 clinical trial (DRIVE) evaluating intravenous iron in dialysis patients with iron-related anemia, sponsored by Wats…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Iron Deficiency Anemia

Drugs mentioned

• Intravenous iron

Snippet

Sponsor: Watson Pharmaceuticals | Conditions: Anemia, Iron-Deficiency, Kidney Failure, Chronic | Phase 4 | Status: COMPLETED